Linggo, Nobyembre 11, 2018

BEAT HepC campaign with HepC survivor Michael De Mesa

“Chronic Hepatitis C infection may lead to serious complications such as cirrhosis and/or liver cancer. Patients with hepatitis C often do not show early symptoms and so it becomes very critical to educate the people about this infection. Early detection is key to treatment and prevention of liver disease progression. The positive news is that treatment for this disease is now easily accessible to all.” ~Dr. Jade Jamias, Liver Specialist and President of HS
Michael De Mesa with members of the Hepatology Society of the Philippines Dr. Edhel Tripon and Dr. Jade Jamias
Many diseases are left undiagnosed and therefore untreated viral Hepatitis is one. As for HSP there are 10% of Filipinos who are suffering from Hepatitis B and there are almost 1 Million Filipinos with Hepatitis C the problem is they still remain untreated because there's lack of awareness among our Filipino people.



People suffering from Hepatitis B or C are at risk of developing Psoriasis and even Liver Cancer. One of Mylan Philippines advocacy is to make a Hepatitis C Free Philippines and during the event, Mylan Incorporation with the Hepatology Society of the Philippines introduces the Beat HepC Campaign.



The drive to eliminate Hepatitis. The cure is simple. The cure is complete. The cure is HERE. A Mylan initiative in coordination with Hepatology Society of the Philippines. Time to be seen. Eliminate Hepatitis beat HEPC. Become Educated, Aware, Tested & Treated.



Mylan, one of the world’s leading global pharmaceutical companies, in association with the Hepatology Society of the Philippines (HSP), launched an awareness campaign for Hepatitis C in the country. The BEATHepC (Become educated, aware, tested and treated) campaign aims at spreading awareness about the disease. It will include dissemination of information through pamphlets and promoting screening among Filipinos at risk.

Hep C survivor and advocate Michael De Mesa

Michael De Mesa and wife Julie Reyes Eigenmann
The Department of Health (DoH) estimates that around 1% of the Filipino population has chronic hepatitis C1. According to the 2010 study on Global Burden of Disease by the Institute for Health Metrics and Evaluation, University of Washington viral hepatitis causes 1 million deaths each year in the Asia Pacific region. Hepatitis C is endemic in the Philippines and there is a lack of awareness about viral hepatitis and its transmission, prevention, screening, and management among patients, public, and healthcare providers.


Mylan’s BEATHepC campaign supports the National Viral Hepatitis Task Force (NVHTF) 2 to eliminate or significantly decrease the prevalence of hepatitis B and hepatitis C in the Philippines. 

Michael De Mesa with members of the Hepatology Society of the Philippines Dr. Edhel Tripon and Dr. Jade Jamias




About Hepatitis C
Hepatitis C is a disease that affects the liver and is caused by the hep C virus. Hep C is usually spread when blood from a person infected with the hep C virus enters the body of someone who is not infected. Hep C generally progresses slowly, over the course of 10 to 40 years. It attacks and damages the liver, killing liver cells in the process. As a result, scar tissue forms, a process called fibrosis. For about 10 to 20 percent of people infected, Hep C can eventually lead to scarring of the liver (also called cirrhosis). Although some people will experience symptoms, about 80 percent of people with acute Hep C do not have any symptoms.

About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.

About Hepatology Society of the Philippines
The Hepatology Society of the Philippines is a non-governmental organization committed to:
  • ·      Provide and promote comprehensive information to the public and to the medical community.
  • ·      Promote research to advance the field of hepatology to provide relevant care to patients.
  • ·      Collaborate with the government in formulating in liver related health policies
  • ·    Share information, services and expertise with the global community towards the prevention and treatment of liver diseases


It is the only liver society recognized by the Philippine Medical Association, Philippine College of Physicians, Philippine Society of Gastroenterology and Philippine Society of Digestive Endoscopy. For further information, visit www.hsp.org.ph







Walang komento:

Mag-post ng isang Komento